Conversely, for HER-2, the AuNP-conjugate sensor is suitable to detect the biomarkers as the immunosensor covers the critical and lower serum concentration (2.0–15 ng mL−1) for healthy patients, and most of the concentration range in women with breast cancer (15–75 ng mL−1) [48]. Here, ERBB2 is linked to breast carcinoma.